AKTS
Aktis Oncology, Inc.
19.70$
-10.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 97.3% | 93.6% | 55.4% | 54.2% | 66.4% | 64.7% | 56.9% | 95.8% | 81.9% | 92.2% | 86.9% | |
| 100.0% | 95.9% | 91.5% | 53.2% | 50.6% | 62.9% | 62.0% | 49.9% | 93.0% | 24.1% | 11.4% | 14.3% | |
| 100.0% | 95.9% | 91.5% | 53.2% | 50.6% | 62.9% | 62.0% | 49.9% | 93.0% | 80.0% | 91.1% | 85.6% | |
| – | – | – | – | 0.7% | 0.6% | 0.5% | 2.4% | – | 3.9% | 1.6% | – | |
| – | 0.7% | 1.0% | 1.0% | 0.2% | 0.2% | 0.2% | 2.5% | – | 6.2% | 0.7% | – | |
| – | – | – | – | – | – | – | 5.0% | – | 11.9% | 2.0% | – | |
| – | 0.7% | 1.6% | 1.1% | 0.9% | 0.8% | 0.8% | 5.6% | – | 12.5% | 3.9% | – | |
| 3.4% | 7.3% | 41.1% | 17.0% | 52.7% | 45.9% | 41.9% | 35.9% | 113.9% | 137.8% | 126.9% | 155.2% | |
| 3.4% | 2.7% | 12.0% | 7.5% | 9.0% | 6.7% | 8.6% | 7.8% | 3.8% | 5.1% | 5.8% | 11.8% | |
| 3.4% | 0.0% | – | – | – | – | 0.6% | 0.2% | 0.6% | 1.2% | 0.4% | 0.5% | |
| – | 0.5% | 1.6% | 2.7% | 0.5% | 0.5% | 3.0% | 2.2% | 0.4% | 0.8% | 0.6% | 0.7% | |
| 96.6% | 92.7% | 58.9% | 83.0% | 47.3% | 54.1% | 58.1% | 64.1% | -13.9% | -37.8% | -26.9% | -55.2% | |
| -2.3% | -28.1% | -146.9% | -87.2% | -130.5% | -140.7% | -145.1% | -128.2% | -14.6% | -39.9% | -28.5% | -59.1% | |
| – | 279.7% | 293.9% | 93.9% | 71.4% | 57.4% | 47.2% | 33.5% | 25.2% | 28.5% | 10.7% | 19.8% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.